This inventor holds 2 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2015-2020.
Company Filing History:
Years Active: 2015-2020
Title: Yuki Terauchi: Innovator in Cancer Treatment
Introduction
Yuki Terauchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, Terauchi is recognized for his dedication to improving therapeutic options for malignant tumors.
Latest Patents
Terauchi's latest patents include a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative. This invention provides an agent for treating malignant tumors, comprising a specific compound formula. Another significant patent involves 4-(methylaminophenoxy)pyridin-3-yl-benzamide derivatives, which present a novel compound exhibiting excellent antitumor effects, stability, and metabolic stability. The compound is represented by a general formula where various substituents are defined, showcasing Terauchi's innovative approach to cancer treatment.
Career Highlights
Yuki Terauchi is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to advance his research in pharmaceuticals. His work focuses on developing effective treatments for cancer, contributing to the company's mission of improving patient outcomes.
Collaborations
Some of Terauchi's coworkers include Kazuya Yamaguchi and Makoto Sakamoto, who collaborate with him on various projects aimed at enhancing cancer therapies.
Conclusion
Yuki Terauchi's contributions to cancer treatment through his innovative patents and research at Otsuka Pharmaceutical Company, Limited, highlight his commitment to advancing medical science. His work continues to inspire and pave the way for future innovations in the field.